These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27620990)

  • 1. Vascular Function and Uric Acid-Lowering in Stage 3 CKD.
    Jalal DI; Decker E; Perrenoud L; Nowak KL; Bispham N; Mehta T; Smits G; You Z; Seals D; Chonchol M; Johnson RJ
    J Am Soc Nephrol; 2017 Mar; 28(3):943-952. PubMed ID: 27620990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease.
    Yelken B; Caliskan Y; Gorgulu N; Altun I; Yilmaz A; Yazici H; Oflaz H; Yildiz A
    Clin Nephrol; 2012 Apr; 77(4):275-82. PubMed ID: 22445470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease.
    Sakai Y; Otsuka T; Ohno D; Murasawa T; Sato N; Tsuruoka S
    Ren Fail; 2014 Mar; 36(2):225-31. PubMed ID: 24152124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients.
    Bayram D; Tuğrul Sezer M; İnal S; Altuntaş A; Kıdır V; Orhan H
    Clin Exp Nephrol; 2015 Jun; 19(3):443-9. PubMed ID: 25082656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Borgi L; McMullan C; Wohlhueter A; Curhan GC; Fisher ND; Forman JP
    Hypertension; 2017 Feb; 69(2):243-248. PubMed ID: 28028194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.
    Kanbay M; Huddam B; Azak A; Solak Y; Kadioglu GK; Kirbas I; Duranay M; Covic A; Johnson RJ
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):1887-94. PubMed ID: 21784838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
    Andrews ES; Perrenoud L; Nowak KL; You Z; Pasch A; Chonchol M; Kendrick J; Jalal D
    PLoS One; 2018; 13(10):e0205831. PubMed ID: 30356327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
    McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J
    Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.
    Gaffo AL; Calhoun DA; Rahn EJ; Oparil S; Li P; Dudenbostel T; Feig DI; Redden DT; Muntner P; Foster PJ; Biggers-Clark SR; Mudano A; Sattui SE; Saddekni MB; Bridges SL; Saag KG
    Arthritis Rheumatol; 2021 Aug; 73(8):1514-1522. PubMed ID: 33779064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients.
    Dogan A; Yarlioglues M; Kaya MG; Karadag Z; Dogan S; Ardic I; Dogdu O; Kilinc Y; Zencir C; Akpek M; Ozdogru I; Oguzhan A; Kalay N
    Blood Press; 2011 Jun; 20(3):182-7. PubMed ID: 21133824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5.
    Liu X; Wang H; Ma R; Shao L; Zhang W; Jiang W; Luo C; Zhai T; Xu Y
    Clin Exp Nephrol; 2019 Mar; 23(3):362-370. PubMed ID: 30291473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
    George J; Carr E; Davies J; Belch JJ; Struthers A
    Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
    Feig DI; Soletsky B; Johnson RJ
    JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of Allopurinol Treatment on Blood Pressure and Renal Function in Patients with Early Stage of Chronic Kidney Disease.
    Satirapoj B; Wirajit O; Burata A; Supasyndh O; Ruangkanchanasetr P
    J Med Assoc Thai; 2015 Dec; 98(12):1155-61. PubMed ID: 27004299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia.
    Tsuji T; Ohishi K; Takeda A; Goto D; Sato T; Ohashi N; Fujigaki Y; Kato A; Yasuda H
    Clin Exp Nephrol; 2018 Dec; 22(6):1300-1308. PubMed ID: 29700702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of renoprotective effects of febuxostat and allopurinol in hyperuricemic patients with chronic kidney disease.
    Lee JW; Lee KH
    Int Urol Nephrol; 2019 Mar; 51(3):467-473. PubMed ID: 30604229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD).
    Sezai A; Soma M; Nakata K; Osaka S; Ishii Y; Yaoita H; Hata H; Shiono M
    J Cardiol; 2015 Oct; 66(4):298-303. PubMed ID: 25649025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study.
    Cicero AFG; Caliceti C; Fogacci F; Giovannini M; Calabria D; Colletti A; Veronesi M; Roda A; Borghi C
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28755406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric Acid Lowering and Biomarkers of Kidney Damage in CKD Stage 3: A Post Hoc Analysis of a Randomized Clinical Trial.
    Perrenoud L; Kruse NT; Andrews E; You Z; Chonchol M; Wu C; Ten Eyck P; Zepeda-Orozco D; Jalal D
    Kidney Med; 2020; 2(2):155-161. PubMed ID: 32964203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.